Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Turn Therapeutics Inc. (TTRX) Market Cap & Valuation Ratios

Turn Therapeutics Inc. (TTRX) has a market cap of $306.2M, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

TTRXTurn Therapeutics Inc.Follow TTRX — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
306.2M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
12 Nov, in 19 days

Peers

drug manufacturers - general · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
TTRX0.3———-1.4%———
RZLT0.4——————-105%
NBP0.4———-5.6%——-587%
GALT0.3———————
CTNM0.3——————-35%
BNTC0.3———-5.5%———
PRLD0.3—6.2—-11.5%+220%-301%-86%
IRD0.3—24.0—-12.2%-36%——
QNRX0.3———-5.4%———
AMRN0.3———6.0%-15%-22%-13%
ABEO0.3—4.7———-328%-157%
Median of these 10—6.2—-5.6%-15%-301%-95%

.

Growth vs. price

each dot a company · hover or tap for values

Turn Therapeutics Inc. — questions

What is Turn Therapeutics Inc.'s market cap?
$306.2M.

Every figure on this page comes from Turn Therapeutics Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.